Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Aminoacyl-tRNA synthetases (aaRSs) catalyze the esterification of tRNA with a cognate amino acid and are essential enzymes in all three kingdoms of life. Due to their important role in the translation of the genetic code, aaRSs have been recognized as suitable targets for the development of small molecule anti-infectives. In this review, following a concise discussion of aaRS catalytic and proof-reading activities, the various inhibitory mechanisms of reported natural and synthetic aaRS inhibitors are discussed. Using the expanding repository of ligand-bound X-ray crystal structures, we classified these compounds based on their binding sites, focusing on their ability to compete with the association of one, or more of the canonical aaRS substrates. In parallel, we examined the determinants of species-selectivity and discuss potential resistance mechanisms of some of the inhibitor classes. Combined, this structural perspective highlights the opportunities for further exploration of the aaRS enzyme family as antimicrobial targets.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916415 | PMC |
| http://dx.doi.org/10.3390/ijms22041750 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acute refractory chorea as a novel phenotype of NARS2 gene mutation-related mitochondrial disorder.
Parkinsonism Relat Disord
September 2025
Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Road, Bengaluru, 560029, Karnataka, India. Electronic address:
Dominant-negative NARS1 R534* mutation causes wild-type subunit poisoning and heterodimer predominance in cells.
J Biol Chem
September 2025
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
Aminoacyl-tRNA synthetases (aaRSs) catalyze the aminoacylation of tRNA with their cognate amino acids, an essential step in protein biosynthesis. While biallelic mutations in aaRSs often result in severe multi-organ dysfunction accompanied by developmental delays, monoallelic mutations typically cause milder, tissue-specific symptoms. However, a de novo monoallelic nonsense mutation (R534*) in the asparaginyl-tRNA synthetase (AsnRS)-resulting in a premature stop codon and 15-residue C-terminal truncation-has been identified in multiple families and is associated with severe neurodevelopmental symptoms.
View Article and Find Full Text PDFIdentification of SARS1 as a Prognostic Biomarker in Invasive Lobular Carcinoma Using Lasso-Logistic Regression.
MicroPubl Biol
August 2025
Department of Biochemistry, Universidad Central del Caribe, Bayamón, Puerto Rico.
Aminoacyl-tRNA synthetases (ARSs) have emerging roles in cancer biology. Specifically, has been linked to immunosuppressive microenvironments and poor prognosis in breast cancer. To identify other ARS genes with prognostic relevance in invasive lobular carcinoma (ILC), we applied lasso-logistic regression to 41 ARS genes using TCGA RNA-seq data and using patient vital status as the binary outcome.
View Article and Find Full Text PDFis a -acting long noncoding RNA that enhances the host interferon response in human epithelial cells.
bioRxiv
August 2025
Department of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, NC.
Long noncoding RNAs (lncRNAs) have been found to play significant regulatory roles within antiviral and immune responses. We previously identified the novel lncRNA virus-inducible lncRNA modulator of interferon response (), that was found to broadly regulate the host transcriptional response to interferon-beta (IFN-β) treatment in A549 human lung epithelial cells. Here, we investigated the mechanism by which regulates the host interferon response in by identifying interacting proteins and gene regulatory networks of .
View Article and Find Full Text PDFA Validated Proteomic Signature of Basal-like Triple-Negative Breast Cancer Subtypes Obtained from Publicly Available Data.
Cancers (Basel)
August 2025
Laboratory of Systems and Synthetic Biology, Wageningen University & Research, Stippeneng 4, 6708 WE Wageningen, The Netherlands.
Background: Basal-like breast cancer (BLBC) is a highly aggressive molecular subtype characterized by the strong expression of a gene cluster found in the basal or outer epithelial layer of the adult mammary gland. Patients with BLBC typically face a poor prognosis, with a shorter disease-free period and overall survival.
Methods: In this study, we explored the proteomic profiles of BLBC patients using publicly available data from two large cohorts of breast cancer patients.